المؤلفون: Ahmed Elshafei, Emad Gamil Khidr, Maher H. Gomaa, Ahmed A. El-Husseiny

المصدر: Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6465-6470 (2021)
Saudi Journal of Biological Sciences

مصطلحات موضوعية: Coronavirus disease 2019 (COVID-19), QH301-705.5, miR-21, microRNA-21, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ACE2, Review, Disease, CVD, cardiovascular disease, Pharmacology, Lung injury, ACE2, angiotensin-converting enzyme 2, TGF-β, transforming growth factor-beta, ACE1, angiotensin-converting enzyme 1, ACEIs, angiotensin-converting enzyme inhibitors, Ang 1-7, angiotensin 1-7, ERK, extracellular signal-regulated kinase, RAAS, renin-angiotensin-aldosterone system, Fibrosis, Angiotensin 1–7, ARBs, angiotensin receptor blockers, Pulmonary fibrosis, Renin–angiotensin system, medicine, AT2R, angiotensin type 2 receptor, ARBs, Biology (General), COVID-19, coronavirus disease 2019, business.industry, AngII, angiotensin II, NLRP3, (NOD, LRR, and pyrin domain-containing protein 3), Angiotensin II, ACEIs, COVID-19, AngI, angiotensin I, medicine.disease, ICU, intensive care unit, AT1R, angiotensin type 1 receptor, AEC-II, alveolar epithelial type II cells, General Agricultural and Biological Sciences, business, MAPK, mitogen-activated protein kinase, hormones, hormone substitutes, and hormone antagonists, Ang 1-9, angiotensin 1-9

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d5f9b3141b315ed573222f71db5af3Test
http://www.sciencedirect.com/science/article/pii/S1319562X2100574XTest

المؤلفون: Therapeutics (Sfpt), Jean-Luc Cracowski, Béatrice Bouhanick, Joachim Alexandre, Vincent Richard

المساهمون: Département de Pharmacologie [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Université de Caen Normandie (UNICAEN), Normandie Université (NU), Hypoxie et PhysioPathologie (HP2), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes (UGA), Endothélium, valvulopathies et insuffisance cardiaque (EnVI), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Therapies
Annales dEndocrinologie
Thérapie
Thérapie, EDP Sciences, 2020, 75, pp.319-325. ⟨10.1016/j.therap.2020.05.009⟩
Therapie

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], Endocrinology, Diabetes and Metabolism, Hemodynamics, Blood Pressure, Angiotensin-Converting Enzyme Inhibitors, Comorbidity, ACEi, angiotensin-converting enzyme inhibitors, ARB, angiotensin II type 1 receptor blockers, Pharmacology, Angiotensin II Type 1 Receptor Blockers, Severity of Illness Index, 030226 pharmacology & pharmacy, Renin-Angiotensin System, 0302 clinical medicine, Endocrinology, RAAS, renin-angiotensin-aldosterone system, COVID-19, coronavirus 2019 infection, Medicine, Pharmacology (medical), Respiratory system, Receptor, Aldosterone, chemistry.chemical_classification, biology, General Medicine, 3. Good health, 030220 oncology & carcinogenesis, Hypertension, Practice Guidelines as Topic, Angiotensin-Converting Enzyme 2, Coronavirus Infections, hormones, hormone substitutes, and hormone antagonists, Arterial hypertension, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, 030209 endocrinology & metabolism, Peptidyl-Dipeptidase A, ACE2, angiotensin-converting enzyme 2, Article, ACE1, angiotensin-converting enzyme 1, Betacoronavirus, 03 medical and health sciences, Downregulation and upregulation, Cell surface receptor, Severity of illness, Renin–angiotensin system, Animals, Humans, cardiovascular diseases, Pandemics, SARS-CoV-2, business.industry, COVID-19, Carboxypeptidase, Angiotensin II, In vitro, COVID-19 Drug Treatment, MRAs, mineralocorticoid receptor antagon, Enzyme, Withholding Treatment, chemistry, Renin-angiotensin-aldosterone system, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b185b52385f9d0dfd6d14a796215acTest